Article
[Drugs for Genetic Myopathy].
Brain and nerve = Shinkei kenkyu no shinpo - 1 May 2023
Oya Yasushi
Abstract excerpt
Specific therapy for genetic myopathy is still limited to enzyme replacement therapy for Pompe disease with alglucosidase alfa and avalglucosidase alfa, and exon skipping therapy with antisense nucleotide viltolarsen for about 7% of patients with Duchenne muscular dystrophy. Corticosteroid treatment (predonisolone 10-15mg/day) to Duchenne muscular dystrophy, from the age of 5-6 years old, regardless of mutations....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
